Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
Stefania Chiappini, Rachel Vickers‐Smith, Daniel R. Harris, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 994-994
Open Access | Times Cited: 33
Using GPT-3 to Build a Lexicon of Drugs of Abuse Synonyms for Social Media Pharmacovigilance
Kristy A. Carpenter, Russ B. Altman
Biomolecules (2023) Vol. 13, Iss. 2, pp. 387-387
Open Access | Times Cited: 23
Misuse, Abuse and Medication Errors’ Adverse Events Associated with Opioids—A Systematic Review
Moa Gustafsson, Vitor Miyashiro-Arias da Silva, Carolina Valeiro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1009-1009
Open Access | Times Cited: 6
Fibromyalgia: do I tackle you with pharmacological treatments?
Serge Perrot
PAIN Reports (2025) Vol. 10, Iss. 1, pp. e1222-e1222
Open Access
Comprehensive evaluation of flumazenil adverse reactions: Insights from FAERS data and signal detection algorithms
M. R. An, J. Jiang
Medicine (2025) Vol. 104, Iss. 10, pp. e41721-e41721
Open Access
Expecting medication misuse: a proactive approach to drug discovery to prevent fatal overdose
Eileen Carry, Ariane Vasilatis, Anatasiya Johnson, et al.
Future Medicinal Chemistry (2025), pp. 1-12
Open Access
Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database
Moa Gustafsson, Cristiano Matos, João Joaquim, et al.
Drug Safety (2023) Vol. 46, Iss. 11, pp. 1133-1148
Closed Access | Times Cited: 11
Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
Kevin Pozsgai, Gergő Szűcs, Anikó Kőnig-Péter, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
Is there a risk for Semaglutide Misuse? Focus on the Food and Drug Administration-FDA Adverse Events Reporting System (FAERS) pharmacovigilance dataset
Stefania Chiappini, Rachel Vickers‐Smith, Duccio Papanti, et al.
(2023)
Open Access | Times Cited: 6
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels’ Decline: A Narrative Review
Nicolò Schifano, Stefania Chiappini, Alessio Mosca, et al.
Brain Sciences (2022) Vol. 12, Iss. 11, pp. 1582-1582
Open Access | Times Cited: 8
Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug─Past and Future
Israel Agranat, Ilaria D’Acquarica
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1409-1416
Open Access | Times Cited: 1
Prescription pattern of usage of analgesics in pain relief in cancer patients at a tertiary care teaching hospital - An observational prospective study
R. Nagarajan, Ahmad Najmi, Saikat Das, et al.
Deleted Journal (2024) Vol. 2, pp. 120-126
Closed Access | Times Cited: 1
New Psychoactive Substances (NPS): A Rising Pandemic in the Mental Health Field?
Stefania Chiappini, Clara Cavallotto, Tommaso Piro, et al.
Sustainable development goals series (2024), pp. 129-140
Closed Access | Times Cited: 1
Effect of oxycodone combined with ultrasound-guided thoracic paravertebral nerve block on postoperative analgesia in patients with lung cancer undergoing thoracoscopic surgery: protocol for a randomised controlled study
Yujie Wang, Guanghan Wu, Zheng Liu, et al.
BMJ Open (2023) Vol. 13, Iss. 10, pp. e074416-e074416
Open Access | Times Cited: 3
Cardiovascular Adverse Events Associated with Monoclonal Antibody Products in Patients with COVID-19
Jingrui Zou, Fuyuan Jing
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1472-1472
Open Access | Times Cited: 5
Trends in co-prescribed opioids and benzodiazepines, non-prescribed opioids and benzodiazepines, and schedule-I drugs in the United States, 2013 to 2019
Shaden A. Taha, Jordan Westra, Danyel H. Tacker, et al.
Preventive Medicine Reports (2023) Vol. 38, pp. 102584-102584
Open Access | Times Cited: 2
Evidence-based successful example of a structure-based approach for the prediction of designer fentanyl-like molecules
Giuseppe Floresta, Valeria Catalani, Vincenzo Abbate
Emerging Trends in Drugs Addictions and Health (2024) Vol. 4, pp. 100143-100143
Open Access
NEURAL NETWORK-BASED ADVERSE DRUG REACTION PREDICTION USING MOLECULAR SUBSTRUCTURE ANALYSES
Shiksha A. Dubey, Prashant S. Kharkar, Anala A. Pandit
International Journal of Applied Pharmaceutics (2024), pp. 337-345
Open Access
Evaluating Quality of Life Changes over 12 Months Among Opiate Users from Romania and Associated Worsening Factors
Melania Lavinia Bratu, Dorel Săndesc, Teodora Anghel, et al.
Life (2024) Vol. 14, Iss. 10, pp. 1336-1336
Open Access
Supply Base attributes and diversion risk in a supply chain for hazardous pharmaceutical products
Paul F. Skilton, Alan W. Mackelprang, Ramin Sepehrirad, et al.
Journal of Operations Management (2024)
Open Access
Metabolic Syndrome as a Risk Factor Among Lebanese Patients with Substance Use Disorder Undergoing Treatment for Recovery Through Rehabilitation or Opioid Substitution Treatment
Nadine Mahboub, Elía M. Ayoub, Christina Mounzer, et al.
Clinics and Practice (2024) Vol. 14, Iss. 6, pp. 2661-2680
Open Access
Level of implementation of the pharmacovigilance program and its associated factors in health institutions in Valle del Cauca
Jobany Castro Espinosa, Hernán Estupiñán Cabrera, María Antonieta Pineda, et al.
Revista Colombiana de Ciencias Químico Farmacéuticas (2024) Vol. 53, Iss. 2, pp. 488-512
Open Access
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration-FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
Stefania Chiappini, Rachel Vickers‐Smith, Daniel R. Harris, et al.
(2023)
Open Access | Times Cited: 1
Implementing Pharmacovigilance at Bathalapalli Hospital to Monitor Adverse Drug Reactions and Improve Patient Care
K Teja
Chettinad Health City Medical Journal (2023) Vol. 12, Iss. 02, pp. 77-82
Open Access | Times Cited: 1
Editorial: Prescribing psychotropics: Misuse, abuse, dependence, withdrawal and addiction, Volume II
Stefania Chiappini, Fabrizio Schifano, Giovanni Martinotti
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 1
Page 1

Scroll to top